Patents by Inventor Amabel Tan

Amabel Tan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240050364
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Application
    Filed: October 10, 2023
    Publication date: February 15, 2024
    Inventors: DAVID CHARLES JACKSON, AMABEL TAN, WEIGUANG ZENG
  • Patent number: 11786458
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Grant
    Filed: May 24, 2022
    Date of Patent: October 17, 2023
    Assignee: ENA RESPIRATORY PTY LTD
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng
  • Publication number: 20220296505
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Application
    Filed: May 24, 2022
    Publication date: September 22, 2022
    Inventors: DAVID CHARLES JACKSON, AMABEL TAN, WEIGUANG ZENG
  • Patent number: 11351114
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: June 7, 2022
    Assignee: ENA THERAPEUTICS PTY LTD
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng
  • Publication number: 20190380952
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Application
    Filed: July 26, 2019
    Publication date: December 19, 2019
    Inventors: DAVID CHARLES JACKSON, AMABEL TAN, WEIGUANG ZENG
  • Patent number: 10406100
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Grant
    Filed: May 16, 2017
    Date of Patent: September 10, 2019
    Assignee: ENA THERAPEUTICS PTY LTD
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng
  • Publication number: 20170246312
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Application
    Filed: May 16, 2017
    Publication date: August 31, 2017
    Inventors: DAVID CHARLES JACKSON, AMABEL TAN, WEIGUANG ZENG
  • Patent number: 9676819
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: June 13, 2017
    Assignee: INNAVAC PTY LTD
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng
  • Publication number: 20130230544
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Application
    Filed: September 22, 2011
    Publication date: September 5, 2013
    Applicant: THE UNIVERSITY OF MELBOURNE
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng